January 3, 2019

Boehringer Ingelheim and Vanderbilt University Announce Partnership to Develop Novel Therapies for Psychiatric Disorders

Boehringer Ingelheim Enhances Central Nervous System Disease Pipeline Vanderbilt Center for Neuroscience Drug Discovery Advances Preclinical Schizophrenia Targets Boehringer Ingelheim and Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) today announced

Velodyne Lidar Showcases a Wide Array of Never-Before-Seen Products at CES

Business Wire India Velodyne Lidar, Inc. will introduce and demonstrate its breakthrough new lidar sensor technology at CES 2019 in the Las Vegas Convention Center North Hall, booth #9010. Velodyne

Lightspeed China Partners Closes on $560 Million of Committed Capital

Lightspeed China Partners (LCP) announced that it has completed the final closing of fund family IV with total committed capital of $560 million, including Lightspeed China Partners IV at $360